CELGENE Trademark
CELGENE is a USPTO trademark filed by Celgene Corporation. Status: Registered.
Trademark Facts
| Mark | CELGENE |
|---|---|
| Serial Number | 76515116 |
| Registration Number | 2888517 |
| Status | Registered |
| Filing Date | 2003-05-19 |
| Registration Date | 2004-09-28 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals), 040 (Material Treatment), 041 (Education & Entertainment), 042 (Software & IT) |
| Owner | Celgene Corporation |
| Attorney of Record | Marilyn F. Kelly |
| Prosecution Events | 38 |
| Latest Event | APRE on 2024-12-20 |
Goods & Services
[ educational classes and programs in the field of thalidomide and safety issues pertaining to thalidomide, and distribution of written materials therewith ]; [ manufacturing pharmaceutical products for others; custom synthesis of DNA to the order and specification of others; custom manufacturing services, namely, manufacturing agrochemicals to the specification of others ]; [ biological preparations for medical purposes, namely for use in the treatment of immunological, inflammatory and neurological disorders; pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment; biological preparations for use in medicinal tests, inoculations, and treatment of diseases, namely, immunological, inflammatory and neurological disorders and cancer; culture media, namely, tissue culture media and bacteriogical culture media for medical use; medicinal and biological preparations for pharmaceutical and clinical use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system ]; [ biochemical catalysts for use in medical research; biological preparations for medical purposes, namely, for use in the research of immunological, inflammatory and neurological disorders; catalysts for use in the manufacture of pharmaceuticals; chemical preparations, namely, chemical reagents for scientific purposes; [ enzyme preparations for industrial purposes; enzymes for industrial purposes; ] proteins for [ industrial and ] human consumption, namely, animal proteins, genetic testing reagents for scientific laboratory use, namely, DNA probes; [ chemical preparations used to protect crops in the agricultural and horticultural field; ] medicinal and biological preparations for medical laboratory use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system ]; research in the fields of chemicals and pharmaceuticals; product safety testing in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely, pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping base on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; providing medical and pharmaceutical research information; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals or diagnostic methods for others [ ; agrochemical product development for others ]